K D Buchanan

1.3k total citations · 1 hit paper
18 papers, 1000 citations indexed

About

K D Buchanan is a scholar working on Surgery, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, K D Buchanan has authored 18 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 4 papers in Epidemiology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in K D Buchanan's work include Helicobacter pylori-related gastroenterology studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Pancreatitis Pathology and Treatment (3 papers). K D Buchanan is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (4 papers), Neuroendocrine Tumor Research Advances (3 papers) and Pancreatitis Pathology and Treatment (3 papers). K D Buchanan collaborates with scholars based in United Kingdom, United States and South Africa. K D Buchanan's co-authors include S. John Swanson, D. Scott Batty, Linda C. Burkly, David M. Harlan, Stuart J. Knechtle, Christopher TenHoor, Allan D. Kirk, John H. Fechner, Robert L. Kampen and Justin D. Berning and has published in prestigious journals such as Nature Medicine, Diabetes and Stroke.

In The Last Decade

K D Buchanan

18 papers receiving 954 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates

1999 666 citations Allan D. Kirk, Linda C. Burkly et al. Nature Medicine profile →

Peers

K D Buchanan

IMMUN

SURGE

TRANS

EPIDE

MB

Joshua Yang United States

Miriam C. Banas Germany

Edward Kim United States

Brigitte Langer Austria

Jan Hörstrup Germany

Martin K. Oaks United States

L A Valdivia United States

Malu Zandbergen Netherlands

Ruediger Waldherr Germany

Josiah Brown United States

Joshua Yang United States

K D Buchanan

150 ×0.3

IMMUN

273 ×0.9

SURGE

244 ×1.0

TRANS

76 ×0.5

EPIDE

174 ×1.4

MB

Citations per year, relative to K D Buchanan K D Buchanan (= 1×) peers Joshua Yang

Countries citing papers authored by K D Buchanan

Since Specialization

Citations

This map shows the geographic impact of K D Buchanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K D Buchanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K D Buchanan more than expected).

Fields of papers citing papers by K D Buchanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K D Buchanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K D Buchanan. The network helps show where K D Buchanan may publish in the future.

Co-authorship network of co-authors of K D Buchanan

This figure shows the co-authorship network connecting the top 25 collaborators of K D Buchanan. A scholar is included among the top collaborators of K D Buchanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K D Buchanan. K D Buchanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Pettengell, Ruth, et al.. (2005). Pegfilgrastim alone successfully mobilizes peripheral CD34+ cells in chemotherapy naive subjects with solid tumors: Initial results of a phase 1–2 study. Biology of Blood and Marrow Transplantation. 11(2). 6–7. 1 indexed citations

2.

Kirk, Allan D., Linda C. Burkly, D. Scott Batty, et al.. (1999). Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nature Medicine. 5(6). 686–693. 666 indexed citations breakdown →

3.

Hess, David C., et al.. (1994). Increased expression of ICAM-1 during reoxygenation in brain endothelial cells.. Stroke. 25(7). 1463–1467. 75 indexed citations

4.

Watson, Richard, C.F. Johnston, M.M.T. O’Hare, et al.. (1989). The Frequency of Gastrointestinal Endocrine Tumours in a Well-defined Population – Northern Ireland 1970–1985. QJM. 72(267). 647–57. 45 indexed citations

5.

Hayes, J. R., et al.. (1988). Serum Concentrations of Trypsin-Like Immunoreactivity and Pancreatic Isoamylase in Insulin Dependent Diabetic Patients. Pancreas. 3(2). 135–139. 3 indexed citations

6.

Silverstein, Faye S., K D Buchanan, Christopher J. Hudson, & Michael V. Johnston. (1986). Flunarizine limits hypoxia-ischemia induced morphologic injury in immature rat brain.. Stroke. 17(3). 477–482. 86 indexed citations

7.

Alberti, K. G. M. M., et al.. (1981). Metabolic importance for gastro entero pancreatic hormones in obesity. Diabetologia. 20(6). 665. 1 indexed citations

8.

Buchanan, K D, et al.. (1980). Gastric inhibitory polypeptide (GIP) responses in diabetes using tiiree different antibodies. Regulatory Peptides. 1. S2–S2. 1 indexed citations

9.

Atkinson, A. B., K D Buchanan, D. J. Carson, et al.. (1978). Insulinoma (apud cell carcinoma) in a diabetic.. BMJ. 2(6149). 1397.2–1398. 9 indexed citations

10.

Doherty, Cathal, K D Buchanan, J. Ardill, & Mary G. McGeown. (1978). Elevations of gastrointestinal hormones in chronic renal failure.. PubMed. 15. 456–65. 15 indexed citations

11.

Doherty, Cathal, et al.. (1977). Cimetidine for duodenal ulceration in patients undergoing haemodialysis.. BMJ. 2(6101). 1506–1508. 14 indexed citations

12.

Doherty, Cathal, et al.. (1977). Treatment of peptic ulcer in renal failure.. PubMed. 14. 386–95. 14 indexed citations

13.

Rooney, Patrick J., et al.. (1976). Serum immunoreactive gastrin in rheumatoid arthritis. Further observations on its identity, clinical specificity, and relationship to gastric function.. Annals of the Rheumatic Diseases. 35(3). 246–250. 9 indexed citations

14.

Herberg, L., Max Berger, K D Buchanan, F. A. Gries, & Hannelore Kern. (1976). Tiermodelle in der diabetesforschung. Metabolische und hormonelle besonderheiten.. The Mouseion at the JAXlibrary (Jackson Laboratory). 91. 3 indexed citations

15.

Kalk, W. J., Aaron I. Vinik, S Bank, et al.. (1974). Glucagon Responses to Arginine in Chronic Pancreatitis: Possible Pathogenic Significance in Diabetes. Diabetes. 23(4). 257–263. 40 indexed citations

16.

Kalk, W. J., Aaron I. Vinik, S Bank, et al.. (1974). Plasma Gastrin Responses to Arginine in Chronic Pancreatitis. Diabetes. 23(4). 264–267. 13 indexed citations

17.

Rooney, Patrick J., et al.. (1974). Proceedings: On the relationship between inflammatory joint disease and the foregut hormones, gastrin and secretin.. Annals of the Rheumatic Diseases. 33(6). 574–575. 1 indexed citations

18.

Kennedy, T, et al.. (1973). An important duodenal role in gastrin release.. PubMed. 60(4). 320–320. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact